Financials
Value Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 1.72 M1.82 M1.83 M — Research & development ——— — Operating income -1.84 M-126.7 M19.32 M — Non-Operating Income, Total 289 K-62.03 M338 K — Interest expense, net of interest capitalized 15.35 M14.6 M13.31 M — Non-Operating Income, excl. Interest Expenses -15.06 M-76.63 M-12.98 M — Unusual income/expense ——— — Pretax income 8.29 M-53.04 M10.09 M — Equity in earnings ——— — Taxes 2.5 M-15.3 M3.14 M — Non-controlling/minority interest ——— — After tax other income/expense ——— — Net income before discontinued operations 5.8 M-37.73 M6.95 M — Discontinued operations ——— — Net income 5.8 M-37.73 M6.95 M — Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders 5.8 M-37.73 M6.95 M — Basic earnings per share (Basic EPS) 0.77-4.120.37 — Diluted earnings per share (Diluted EPS) 0.75-4.120.8 — Average basic shares outstanding 7.53 M9.17 M8.7 M — Diluted shares outstanding 7.69 M9.17 M8.7 M — EBITDA ——— — EBIT -1.82 M-127.01 M5.95 M — Cost of revenue 925 K1.35 M2.84 M — Other cost of goods sold ——— — Depreciation & amortization (cash flow) ——— —